1. Bulavin LA, Goncharenko NA, Dmytrenko OP et al (2019) Heteroassociation of antitumor agent doxorubicin with bovine serum albumin in the presence of gold nanoparticles. J Mol Liq 284:633–638
2. Connie R, Yael A, Jung HC et al (2013) Book biology. OpenStax College, Houston, p 501. ISBN:9781947172029
3. Gaussian 09, Revision A.02, Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H, Li X, Caricato M, Marenich A, Bloino J, Janesko BG, Gomperts R, Mennucci B, Hratchian HP, Ortiz JV, Izmaylov AF, Sonnenberg JL, Williams-Young D, Ding F, Lipparini F, Egidi F, Goings J, Peng B, Petrone A, Henderson T, Ranasinghe D, Zakrzewski VG, Gao J, Rega N, Zheng G, Liang W, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Throssell K, Montgomery JA Jr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Keith T, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Millam JM, Klene M, Adamo C, Cammi R, Ochterski JW, Martin RL, Morokuma K, Farkas O, Foresman JB, Fox DJ (2016) Gaussian, Inc., Wallingford
4. Goncharenko NA, Pavlenko OL, Kulish MP et al (2019) Gold nanoparticles as factor of influence on doxorubicin-bovine serum albumin complex. Appl Nanosci (switz) 9(5):825–833
5. Goncharenko NA, Dmytrenko OP, Kulish MP et al (2020a) Mechanisms of the interaction of bovine serum albumin with anticancer drug gemcitabine. Mol Cryst Liq Cryst 701:59–71